key: cord-1034872-ckurlvoq
authors: Rokohl, Alexander C.; Loreck, Niklas; Wawer Matos, Philomena A.; Zwingelberg, Sarah; Augustin, Max; Dewald, Felix; Grajewski, Rafael S.; Klein, Florian; Lehmann, Clara; Heindl, Ludwig M.
title: More than loss of taste and smell: burning watering eyes in coronavirus disease 19 (COVID-19)
date: 2020-08-21
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.08.018
sha: 9e493a41d6b4143f83add4cdb76b46dbed37bc8e
doc_id: 1034872
cord_uid: ckurlvoq

OBJECTIVES: To evaluate ocular symptoms in European non-hospitalized patients with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and to investigate associations with the demographic data as well as nasal and general physical symptoms. METHODS: In this prospective, observational study, 108 non-hospitalized patients with polymerase chain reaction (PCR) confirmed SARS-CoV-2 infection not requiring intensive care were asked using a standardized questionnaire regarding disease associated ocular symptoms, demographic data, as well as general physical and nasal symptoms. Total ocular symptom score (TOSS) was evaluated during and retrospectively prior to coronavirus disease 19 (COVID-19) infection. Associations between TOSS and demographic data as well as general and nasal symptoms were evaluated. RESULTS: 75 out of the 108 COVID-19 patients (69.4 %) suffered from at least one ocular symptom during COVID-19. The most common symptoms included burning sensations in 36.1% (n=39), epiphora in 34.3% (n=37), and redness in 25.9% (n=28), compatible with conjunctivitis. These symptoms occurred 1.96 ± 3.17 days after the beginning of COVID-19 and were rather mild. TOSS was significantly higher during COVID-19 (1.27±1.85) than prior to the infection (0.33±1.04; p<0.001). There were no significant associations between TOSS and gender (beta coefficient: -0.108; p=0.302), age (-0.024; p=0.816), rhinorrhea (-0.127; p=0.353), nasal itching (-0.026; p=0.803), sneezing (0.099; p=0.470), nasal congestion (-0.012; p=0.930), cough (-0.079; p=0.450), headache (0.102; p=0.325), sore throat (0.208; p=0.052), or fever (0.094; p=0.361). CONCLUSIONS: Ocular involvement in European non-hospitalized patients with COVID-19 seems to be highly underestimated. Overall, these ocular symptoms including burning sensations, epiphora, and redness seem to be mild and seem not to need any treatment.

chain reaction (PCR) confirmed SARS-CoV-2 infection not requiring intensive care were asked using 35 a standardized questionnaire regarding disease associated ocular symptoms, demographic data, as well 36 as general physical and nasal symptoms. Total ocular symptom score (TOSS) was evaluated during 37 and retrospectively prior to coronavirus disease 19 infection. Associations between 38 TOSS and demographic data as well as general and nasal symptoms were evaluated.

Results: 75 out of the 108 COVID-19 patients (69.4 %) suffered from at least one ocular symptom 41 during COVID-19. The most common symptoms included burning sensations in 36.1% (n=39), 42 epiphora in 34.3% (n=37), and redness in 25.9% (n=28), compatible with conjunctivitis. These 43 symptoms occurred 1.96 ± 3.17 days after the beginning of COVID-19 and were rather mild. TOSS 44 was significantly higher during 

Conclusions: Ocular involvement in European non-hospitalized patients with COVID-19 seems to be 51 highly underestimated. Overall, these ocular symptoms including burning sensations, epiphora, and 52 redness seem to be mild and seem not to need any treatment.

The rapid spread of coronavirus disease 2019 were asked using a standardized three-section questionnaire. Section 1 requested demographic data, 90 general symptoms including fever, cough, headache, and sore throat as well as dates of the positive 91 PCR test and of the first symptoms associated with COVID-19. Nasal symptoms which might 92 influence ocular symptoms potentially were evaluated for nasal congestion, sneezing, nasal itching, 93 and rhinorrhea using a four-point scale (0-3), respectively [7] . A score of 0 indicated no symptoms, 1 94 documented mild symptoms that were easily tolerated, 2 described awareness of symptoms which 95 were bothersome but tolerable, and 3 matched severe symptoms that were hard to tolerate and 96 interfered with daily activities or sleep. 97 Section 2 asked for ocular symptoms during COVID-19 including burning sensations, itching, 98 watering, mucoid and purulent discharge, photophobia, foreign body sensation, conjunctival swelling, 99 eye lid swelling, feeling of pressure, double images, metamorphopsia, redness, reduced visual acuity, 100 and pain for the right and the left eye, respectively. Furthermore, the date of the beginning of each

115 non-hospitalized patients with COVID-19 were called and 109 of them were achieved by phone. 139 108 agreed to participate, 1 declined. Of these 108 patients, 51 were males and 57 females with a 140 mean age of 37.9 ± 13.7 years (range, 18 -87 years). Mean time since PCR confirmed COVID-19 was 141 6.8 ± 1.5 days (range, 3 -9 days), and mean time since first symptoms occurred was 13.2 ± 3.8 days (Table 1) . These ocular symptoms occurred 149 mostly in the first three days after any symptom of COVID-19 was noticed. All scores were 150 significantly higher during COVID-19 than the scores prior to infection (p≤0.022, respectively; Table   151 2). Prior to COVID-19, two patients had previously diagnosed dry eye disease and one patient ocular 152 allergy while six patients used sometimes artificial tears if needed and one patient antihistamines.

During COVID-19 only one patient bought artificial tears and no patient was seen by an 154 ophthalmologist. None of the investigated explanatory variables including gender, age, rhinorrhea, 155 nasal itching, sneezing, nasal congestion, cough, headache, fever, and sore throat was associated with 156 TOSS during COVID-19 (ANOVA: p=0.559; p≥0.05, respectively).

This prospective study showed for the first time the high prevalence of burning sensation, redness, and 166 watering in non-hospitalized European COVID-19 patients. The consecutively enrolled patients were 167 much younger than in previous studies including mostly inpatients in China [3, 6] . Younger patients 168 without any preexisting conditions have normally a mild course of disease and need therefore not be 169 hospitalized. Approximately one-third of the outpatients in this study had epiphora or burning 170 sensations, respectively, and one fourth reported ocular redness. Therefore, the incidence of 171 conjunctivitis, especially in outpatients, seems to be highly underestimated. Ocular symptoms 172 occurred mostly in the first three days of COVID-19, but were usually rather mild. However, in some 173 rare cases moderate or severe courses including subconjunctival bleedings, keratitis, or even vitreous 174 hemorrhages can occur [8, 9] .

The reasons why patients had no ophthalmologist's visit despite a high incidence of symptoms, stay 176 unclear. The mild disease, fear of infection, and/or the home quarantine order by the health authorities 177 might be possible reasons.

Since ocular symptoms were not associated with nasal symptoms, cough, headache, fever, or sore 179 throat, these concomitant COVID-19 symptoms seem to have no significant impact on the ocular 180 symptoms. Therefore, SARS-CoV-2 might have a significant causative influence on these ocular J o u r n a l P r e -p r o o f 

Olfactory and Gustatory Dysfunction in Coronavirus 220 Disease 19 (COVID-19)

Letter to the Editor: A Missing Link between 222

SARS-CoV-2 and the Eye?: ACE2 Expression on the Ocular Surface

Clinical Characteristics of Coronavirus Disease

The New England journal of medicine

SARS-CoV-2 entry factors are highly expressed in 227 nasal epithelial cells together with innate immune genes

Characteristics of Ocular Findings of Patients With Coronavirus 231 Disease

The Allergic Rhinitis

AR-CIC): nasal allergen challenge protocol optimization for studying AR 234 pathophysiology and evaluating novel therapies